Skip to main content

Table 3 Treatment-related toxicities

From: Consolidation chemotherapy may improve survival for patients with locally advanced non-small-cell lung cancer receiving concurrent chemoradiotherapy - retrospective analysis of 203 cases

Toxicity

CRT phase

CCT phase

CCT (%)

Non-CCT (%)

Total

p-value

CCT (%)

Non-CCT (%)

Total

p-value

Hematological

   

0.509

   

-

 Grade 3/4

34 (30.1)

31 (34.4)

65 (32.0)

 

17 (15.0)

-

-

 

 Grade 1/2

79 (69.9)

59 (65.6)

138 (68.0)

 

96 (85.0)

-

-

 

Esophagitis

   

0.422

   

-

 Grade 3

11 (9.7)

12 (13.3)

23 (11.3)

 

-

-

-

 

 Grade 1/2

102 (90.3)

78 (86.7)

180 (88.7)

 

-

-

-

 

Radiation pneumonitis

   

0.195

    

 Grade ≥ 3

0 (0.0)

2 (2.2)

2 (1.0)

 

6 (5.3)

3 (3.3)

9 (4.4)

0.737

 Grade 1/2

113 (100.0)

88 (97.8)

201 (99.0)

 

107 (94.7)

87 (96.7)

194 (95.6)